Status:

RECRUITING

A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Psychotic Disorders

Mood Disorders

Eligibility:

All Genders

18-30 years

Phase:

NA

Brief Summary

This is a randomized controlled trial testing the efficacy of Resilience Training in college students with elevated transdiagnostic risk for developing a serious mental illness.

Detailed Description

This is a definitive, randomized controlled trial that will measure the efficacy of Resilience Training, a four-session group-based behavioral intervention conducted in transdiagnostically at-risk you...

Eligibility Criteria

Inclusion criteria:

  1. 18-30 years old
  2. Enrolled as a first or second year student (i.e., freshman or sophomore) in an undergraduate program at the college or university where the intervention takes place
  3. Students who endorse some psychotic experiences (Peter's et al. Delusion Inventory (PDI) score > 3)

Exclusion criteria:

  1. Inability to provide informed consent
  2. Not proficient in English
  3. Current self-reported Diagnostic Statistical Manual 5 (DSM-5) diagnosis with active symptoms (such as active psychotic symptoms, current suicidality, serious active alcohol or substance use, marked deterioration in functioning over the prior month) determined by clinical interview with participant, or self-report of a psychiatric diagnosis that necessitates close monitoring or individual therapy and/or inpatient or partial hospitalization
  4. Current enrollment in psychological or behavioral health treatment.
  5. Current use of psychotropic medications (other than stimulants) prescribed by a physician.
  6. A diagnosis of a serious, chronic mental illness as determined by the Mini-International Neuropsychiatric Interview (MINI)

Key Trial Info

Start Date :

February 10 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2029

Estimated Enrollment :

192 Patients enrolled

Trial Details

Trial ID

NCT06929442

Start Date

February 10 2025

End Date

June 1 2029

Last Update

April 17 2026

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Charlestown, Massachusetts, United States, 02129